Net Cash Provided by (Used in) Operating Activities |
-4.84M |
USD |
-9.73% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
2.3M |
USD |
-52.8% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
2.65M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-2.54M |
USD |
-637% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.29M |
USD |
-72.6% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
131K |
USD |
|
Q2 2024 |
Q2 2024 |
Deferred Income Tax Expense (Benefit) |
-26.6K |
USD |
-381% |
Q1 2024 |
Q1 2024 |
Preferred Stock, Shares Authorized |
500K |
shares |
0% |
Q2 2024 |
Q2 2024 |
Depreciation, Depletion and Amortization |
6.25K |
USD |
0% |
Q1 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
10 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |